Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Immunitybio Inc (IBRX)

Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0800 (unch)
BVAXF : 0.0595 (-4.80%)
MRNA : 122.64 (-2.35%)
BOLD : 8.95 (-1.10%)
IBRX : 8.90 (-0.78%)
MGNX : 16.07 (+5.58%)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 22.10 (-1.43%)
BIOV.CN : 0.0800 (unch)
BVAXF : 0.0595 (-4.80%)
MRNA : 122.64 (-2.35%)
BOLD : 8.95 (-1.10%)
IBRX : 8.90 (-0.78%)
MGNX : 16.07 (+5.58%)
Biotech Sector Advances in Pancreatic Cancer Research

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 22.10 (-1.43%)
ONCY : 1.1701 (+0.01%)
ONC.TO : 1.61 (+1.26%)
NVS : 97.39 (+0.05%)
IBRX : 8.90 (-0.78%)
ACRS : 1.3450 (+2.67%)
NUVB : 3.24 (-0.92%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 2.28 (unch)
ONCY : 1.1701 (+0.01%)
ONC.TO : 1.61 (+1.26%)
NVS : 97.39 (+0.05%)
IBRX : 8.90 (-0.78%)
ACRS : 1.3450 (+2.67%)
NUVB : 3.24 (-0.92%)
Should You Still Buy the Nasdaq's Best-Performing October Stocks?

Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them.

COMP : 3.40 (+7.26%)
GPCR : 39.46 (+1.21%)
IBRX : 8.90 (-0.78%)
OLK : 23.00 (-0.09%)
Why Shares of ImmunityBio Jumped This Week

The company's founder is spending his own money to help finance the business's efforts.

IBRX : 8.90 (-0.78%)
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. (IBRX) Shareholders

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ImmunityBio, Inc. (NASDAQ: IBRX)...

IBRX : 8.90 (-0.78%)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc.(IBRX) Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ImmunityBio, Inc. ("ImmunityBio" or the "Company") (NASDAQ: IBRX) of a class action securities...

IBRX : 8.90 (-0.78%)
IBRX FINAL DEADLINE TUESDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ImmunityBio, Inc. (NASDAQ: IBRX) between May 23,...

IBRX : 8.90 (-0.78%)
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit

/PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

IBRX : 8.90 (-0.78%)

Barchart Exclusives

Apple Stock Surges on Buyback and Dividend News - OTM Options are Cheap Here
Apple stock is up on its massive buyback news - a new $110 billion program, as well as a 4% dividend hike. These work out to 4.39% of its market cap. Today AAPL OTM put and call options are cheap - good for long-term investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar